Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 3, 2013, Pages 316-325

  Shim, Ju Hyun ^a   Han, Seungbong ^a   Shin, Yong Moon ^a   Yu, Eunsil ^a   Park, Wonhyeong ^a   Kim, Kang Mo ^a   Lim, Young Suk ^a   Lee, Han Chu ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

complete response; CR; EASL; European Association for the Study of the Liver; HBV; HCC; hepatitis B virus; hepatocellular carcinoma; modified Response Evaluation Criteria In Solid Tumors; mRECIST; RECIST; Response Evaluation Criteria In Solid Tumors; WHO; World Health Organization

Indexed keywords

CISPLAN; CISPLATIN; IODINATED POPPYSEED OIL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ASSESSMENT TOOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DISEASE SEVERITY; EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER CRITERIA; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MODIFIED RESPONSE EVALUATION CRITERIA IN SOLID TUMOR CRITERIA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR NECROSIS;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; DRUG CARRIERS; ETHIODIZED OIL; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NECROSIS; NEOPLASM STAGING; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874762925     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2012.10.022     Document Type: Article

References (30)

1. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
2. D.B. Brown, J.E. Gould, and D.A. Gervais Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria J Vasc Interv Radiol 20 suppl 2009 S425 S434
3. K. Takayasu, S. Arii, and N. Matsuo Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma AJR Am J Roentgenol 175 2000 699 704
4. J.H. Shim, H.C. Lee, and S.O. Kim Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models Radiology 262 2012 708 718
5. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
6. A. Forner, C. Ayuso, and M. Varela Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 2009 616 623
7. J. Lammer, K. Malagari, and T. Vogl Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 2010 41 52
8. S. Herber, S. Biesterfeld, and U. Franz Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome Cardiovasc Intervent Radiol 31 2008 768 777
9. I. Bargellini, C. Vignali, and R. Cioni Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria - selection parameter for liver transplantation Radiology 255 2010 289 300
10. S.J. Hunt, W. Yu, J. Weintraub, M.R. Prince, and N. Kothary Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation J Vasc Interv Radiol 20 2009 30 38
11. R. Kloeckner, G. Otto, S. Biesterfeld, K. Oberholzer, C. Dueber, and M.B. Pitton MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma Cardiovasc Intervent Radiol 33 2010 532 540
12. J.H. Shim, K.M. Kim, and Y.J. Lee Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection Ann Surg Oncol 17 2010 869 877
13. D. Warr, S. McKinney, and I. Tannock Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response J Clin Oncol 2 1984 1040 1046
14. T. Ichikawa, K. Saito, and N. Yoshioka Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease Invest Radiol 45 2010 133 141
15. A. Riaz, R.J. Lewandowski, and L. Kulik Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization Cardiovasc Intervent Radiol 33 2010 1143 1152
16. A. Riaz, K. Memon, and F.H. Miller Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation J Hepatol 54 2011 695 704
17. L. Goodman, and W. Kruskal Measures of association for cross classifications, IV: simplification of asymptotic variances J Am Stati Assoc 67 1972 415 421
18. J. Cohen Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit Psychol Bull 70 1968 213 220
19. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
20. S.W. Shin The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma Korean J Radiol 10 2009 425 434
21. B.I. Choi, H.C. Kim, and J.K. Han Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings Radiology 182 1992 709 713
22. C. Valls, J.J. Pamies, and C. Sancho Computed tomography after Lipiodol chemoembolization in hepatocellular carcinoma Eur Radiol 4 1994 238 242
23. B.S. Kuszyk, J.K. Boitnott, and M.A. Choti Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model Radiology 217 2000 477 486
24. H.C. Kim, A.Y. Kim, and J.K. Han Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images Radiology 225 2002 773 780
25. J.S. Yu, K.W. Kim, K.B. Sung, J.T. Lee, and H.S. Yoo Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging Radiology 203 1997 737 742
26. S.H. Kim, J. Lee, and M.J. Kim Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma AJR Am J Roentgenol 192 2009 1675 1681
27. Y.S. Guan, L. Sun, X.P. Zhou, X. Li, and X.H. Zheng Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up World J Gastroenterol 10 2004 3543 3548
28. A. Riaz, L. Kulik, and R.J. Lewandowski Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres Hepatology 49 2009 1185 1193
29. L. Mannelli, S. Kim, C.H. Hajdu, J.S. Babb, T.W. Clark, and B. Taouli Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver AJR Am J Roentgenol 193 2009 1044 1052
30. S. Bonekamp, P. Jolepalem, M. Lazo, M.A. Gulsun, A.P. Kiraly, and I.R. Kamel Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data Radiology 260 2011 752 761